Evidence map›Paper›PMID 19616444›Full record

ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2010

Calcium sensitisation impairs diastolic relaxation in post-ischaemic myocardium: implications for the use of Ca(2+) sensitising inotropes after cardiac surgery.

Yeong-Hoon Choi, Douglas B Cowan, Thorsten C W Wahlers, Roland Hetzer, Pedro J Del Nido, Christof Stamm

Open access · bronzeAbstract read
In one paragraph

Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. The effect of intravenous calcium administration on haemodynamics in perioperative cardiothoracic surgery and intensive care: A narrative review.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Yeong-Hoon ChoiHeart Center of the University of Cologne, Department of Cardiothoracic Surgery, Cologne, Germany. yh.choi@uk-koeln.de
Douglas B Cowan
Thorsten C W Wahlers
Roland Hetzer
Pedro J Del Nido
Christof Stamm
Deutsches Herzzentrum der Charité · DEBoston Children's Hospital · USBoston University · USUniversity Hospital Cologne · DEUniversity of Cologne · DE

Funding

Engineering of Pacemaker Tissue for Cardiac ImplantationR01HL068915 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI COWAN, DOUGLAS BURR · 2002 to 2009
$2.9M
Expansion and Directed Differentiation of Adult Side Population Stem CellsR01HL088206 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI COWAN, DOUGLAS BURR · 2007 to 2011
$1.9M
NHLBI NIH HHS R01 HL068915NHLBI NIH HHS R01 HL088206
6 · The paper itself

Abstract

backgroundCalcium sensitising inotropes are increasingly being used in cardiac surgical patients. Theoretically, increasing contractile protein sensitivity to Ca(2+) prevents the Ca(2+) elevation associated arrhythmogenicity and potentiates the inotropic effect of catecholamines. On the other hand, we hypothesised that Ca(2+) sensitisation exacerbates post-ischaemic myocardial stunning by impairing diastolic relaxation, which might have deleterious effects in postoperative cardiac surgical patients.

methodsIn an isolated rabbit heart model, 45 min normothermic ischaemia with potassium-induced cardioplegic arrest was followed by 120 min reperfusion. Isovolumetric left ventricular (LV) function and myocardial oxygen consumption (MvO(2)) were measured, and cytosolic Ca(2+) was monitored by rhod-2 surface spectrofluorometry. During reperfusion, ORG 30029 (250 microM) and levosimendan (0.5 microM) were used as Ca(2+) sensitisers (ORG, n=6, Levo, n=6), Ca(2+) de-sensitisation was induced with butanedione-monoxime (5mM, BDM, n=6), and dopamine (20 nM) served as a representative catecholamine (n=6). To counteract the PDE III inhibiting properties of ORG and Levo, IGF-1 (0.1 microM) and parathyroid hormone (0.05 microM) were used.

resultsAs expected, ischaemia/reperfusion induced moderate cytosolic calcium overload. Dopamine increased LV contractility and MvO(2) by augmenting the amplitude of the Ca(2+) transient, but relaxation was unchanged due to faster diastolic Ca(2+) removal. Dopamine-induced Ca(2+) handling was unchanged after uncoupling the Mg-ATPase with BDM, and MvO2 decreased in proportion with the reduced LV mechanical work load. ORG improved contractility without apparent effects on Ca(2+) handling, and MvO(2) remained constant despite increased contractile work. Conversely, ORG induced a rightward shift of the diastolic pressure-volume relationship in post-ischaemic hearts (diastolic pressure at 0.8 ml balloon volume 14.3+/-5 mmHg, p=0.01 vs control), but not in non-ischaemic control hearts. With levosimendan, the Ca(2+) sensitising effects were less pronounced (7.6+/-3 mmHg, p=0.4 vs control). By counteracting the PDE inhibiting effects of ORG and Levo using parathyroid hormone and IGF-1, the negative lusotropic effects of Ca(2+) sensitisation were unmasked.

conclusionsCalcium sensitisation improves systolic function and energetic efficiency. However, Ca(2+) sensitisers should be used with caution during post-ischaemic reperfusion, as they may exacerbate myocardial stunning and thus impair cardiac output.

Indexed as

AnimalsCa(2+) Mg(2+)-ATPaseCalciumCardiotonic AgentsCyclic Nucleotide Phosphodiesterases, Type 3CytosolDiacetylDiastoleDopamineEnzyme InhibitorsHydrazonesMyocardial ContractionMyocardial Reperfusion InjuryMyocardial StunningOrgan Culture TechniquesOrganic ChemicalsCa(2+) Mg(2+)-ATPaseCalciumCardiotonic AgentsCyclic Nucleotide Phosphodiesterases, Type 3DiacetyldiacetylmonoximeDopamineEnzyme InhibitorsHydrazonesORG 30029Organic ChemicalsPyridazinesSimendan

Identifiers

PMID19616444
PMCPMC4335314
OpenAlexW2034608515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.